Novel transcript, antisense to DAPK2 (ENSG00000259351)

This molecule is a long non-coding RNA (lncRNA) transcribed antisense to the DAPK2 gene, officially cataloged as ENSG00000259351 (also known as LOC101928988). Antisense lncRNAs are known to regulate transcriptional and post-transcriptional processes of overlapping or nearby genes. In this case, it may regulate DAPK2, a serine/threonine kinase involved in apoptosis, autophagy, cytoskeletal regulation, and tumor suppression. Functional studies on LOC101928988 specifically are limited, but it may influence cell death and autophagy indirectly through effects on DAPK2 expression or signaling. There is no evidence that this lncRNA itself is a therapeutic target, nor that it is currently implicated in drug interactions or used as a biomarker. Summary: ENSG00000259351/LOC101928988 is a regulatory, non-coding RNA not considered a canonical drug target or disease biomarker, but may have roles in transcriptional regulation of the DAPK2 gene. No interacting drugs, safety concerns, or therapeutic mechanisms have been documented for this lncRNA.

Other names

ENSG00000259351LOC101928988Novel transcript, antisense to DAPK2

Not applicable for drugs, but mechanistically as an antisense lncRNA it may bind to the DAPK2 locus or transcript to regulate its transcription, stability, or splicing